Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lobular Carcinoma In Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00555152
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ

Who this might be right for
Ductal Breast Carcinoma In SituHER2/Neu Positive
National Cancer Institute (NCI) 22
Not applicableActive Not RecruitingNCT00907868
What this trial is testing

Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS)

Who this might be right for
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 2,004
Not applicableActive Not RecruitingNCT05318274
What this trial is testing

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Who this might be right for
Ductal Breast Carcinoma in SituInvasive Breast CancerEarly-stage Breast Cancer+4 more
Coordinación de Investigación en Salud, Mexico 72
Large-scale testing (Phase 3)WithdrawnNCT00324714
What this trial is testing

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

Who this might be right for
Breast CancerOsteoporosis
ETOP IBCSG Partners Foundation
Large-scale testing (Phase 3)Not Yet RecruitingNCT07554573
What this trial is testing

Assessment of Biosignature Classification of DCIS for RadioTherapy Benefit Post Lumpectomy (ABCD RT)

Who this might be right for
Breast Cancer
NRG Oncology 5,270
Not applicableStudy completedNCT00666731
What this trial is testing

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Who this might be right for
Breast CancerPrecancerous Condition
University of Nebraska 4,945
Not applicableStudy completedNCT00665782
What this trial is testing

Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast

Who this might be right for
Anxiety DisorderBreast CancerDepression+1 more
Wake Forest University Health Sciences 24
Testing effectiveness (Phase 2)Ended earlyNCT00096369
What this trial is testing

Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 130
Not applicableStudy completedNCT02908178
What this trial is testing

Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ

Who this might be right for
Ductal Carcinoma In Situ
Yale University 28,291
Not applicableWithdrawnNCT03437915
What this trial is testing

BrUOG 351: PRE-OPERATIVE APBI USING NIBB

Who this might be right for
Breast CancerInvasive Breast CancerDuctal Carcinoma in Situ
Jaroslaw Hepel
Not applicableNot Yet RecruitingNCT07492043
What this trial is testing

Breast Tumour Size Measurement by Field Cycling Imaging

Who this might be right for
Breast CancerDuctal Carcinoma In Situ
University of Aberdeen 12
Post-approval studies (Phase 4)Study completedNCT04248179
What this trial is testing

The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Zealand University Hospital 36
Not applicableStudy completedNCT00620087
What this trial is testing

Molecular Breast Imaging in Women With Atypia and LCIS

Who this might be right for
Atypical Lobular HyperplasiaAtypical Ductal HyperplasiaLobular Carcinoma in Situ
Mayo Clinic 66
Testing effectiveness (Phase 2)UnknownNCT00077168
What this trial is testing

Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 2,000
Testing effectiveness (Phase 2)Temporarily pausedNCT06538389
What this trial is testing

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+5 more
City of Hope Medical Center 36
Not applicableStudy completedNCT01628536
What this trial is testing

A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ

Who this might be right for
Ductal Carcinoma in Situ
Yale University 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT04009044
What this trial is testing

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Who this might be right for
Cancer SurvivorDuctal Breast Carcinoma In SituInvasive Breast Carcinoma
Northwestern University 156
Testing effectiveness (Phase 2)Ended earlyNCT01754519
What this trial is testing

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor NegativeEstrogen Receptor Positive+12 more
Roswell Park Cancer Institute 1
Large-scale testing (Phase 3)Study completedNCT00438659
What this trial is testing

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast CancerDermatologic ComplicationsRadiation Toxicity+1 more
North Central Cancer Treatment Group 176
Not applicableStudy completedNCT00719966
What this trial is testing

Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 109
Next Page